PD-L1 Expression after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancers Is Associated with Aggressive Residual Disease, Suggesting a Potential for Immunotherapy

por Grandal, Beatriz, Mangiardi-Veltin, Manon, Laas, Enora, Laé, Marick, Meseure, Didier, Bataillon, Guillaume, El-Alam, Elsy, Darrigues, Lauren, Dumas, Elise, Daoud, Eric, Vincent-Salomon, Anne, Talagrand, Laure-Sophie, Pierga, Jean-Yves, Reyal, Fabien, Hamy, Anne-Sophie
Publicado 2021

Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer

por Hamy, Anne-Sophie, Derosa, Lisa, Valdelièvre, Constance, Yonekura, Satoru, Opolon, Paule, Priour, Maël, Guerin, Julien, Pierga, Jean-Yves, Asselain, Bernard, De Croze, Diane, Pinheiro, Alice, Lae, Marick, Talagrand, Laure-Sophie, Laas, Enora, Darrigues, Lauren, Grandal, Beatriz, Marangoni, Elisabetta, Montaudon, Elodie, Kroemer, Guido, Zitvogel, Laurence, Reyal, Fabien
Publicado 2019